1. 2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma. (September 2015) Authors: Ducoulombier, A.; Quintin, J.; Desjardin, M.; Hautefeuille, V.; Desauw, C.; Parzy, A.; Bouche, O.; Chauffert, B.; Clisant, S.; El Hajbi, F.; Becouarn, Y.; Bennouna, J.; Hebbar, M.; Penel, N.; Adenis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗